Filing Impact
Filing Sentiment
Form Type
4
Quidel
Aug 21, 2025
QuidelOrtho Completes Debt Refinancing
Aug 21, 2025
Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities
Aug 19, 2025
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
Aug 13, 2025
QuidelOrtho Launches Certified Analyzer Program
Aug 21, 2025
[8-K] QuidelOrtho Corporation Reports Material Event
Jul 29, 2025
[SCHEDULE 13G/A] QuidelOrtho Corporation SEC Filing
1.89B
66.81M
0.92%
117.81%
9.7%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
United States
SAN DIEGO